Clinical Trial Update: Acute Changes in Intraocular Cytokines After Intravitreal Bevacizumab [NA]

View source ↗

Summary

Clinical trial update on acute changes in intraocular cytokines after intravitreal bevacizumab in patients with diabetic complications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Diabetic Retinopathy

Drugs mentioned

• Bevacizumab (Avastin) (bevacizumab)

Snippet

Sponsor: Seoul St. Mary's Hospital | Conditions: Complications of Diabetes Mellitus | NA | Status: UNKNOWN